Clinical Trial

A Phase II Clinical Study of LT3001 for Injection in the Treatment of Acute Ischemic Stroke

Name: A Phase II Clinical Study of LT3001 for Injection in the Treatment of Acute Ischemic Stroke — clinical trial record (NCT07754825)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This phase II clinical study is designed to evaluate the efficacy and safety of LT3001 in the treatment of acute ischemic stroke

Trial Details

NCT Number	NCT07754825
Lead Sponsor	Shanghai Pharmaceuticals Holding Co., Ltd
Conditions	Acute Ischemic Stroke
Enrollment	300 participants
Start Date	2026-09-01
Primary Completion	2027-12-31 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-08-10